Get started
Author

П. С. Пухтинская

Observed names: P. Pukhtinskaia, P. S. Puhtinskaya, P. S. Pukhtinskaia, P. S. Pukhtinskaya, P.S. Pukhtinskaia, Polina P. Pukhtinskaia, Polina Pukhtinskaia, Polina S. Pukhtinskaia, Пухтинская П. С.
Institution: BIOCAD (Russia)
ORCID: 0000-0001-9790-8207
Observed ORCID: 0000-0001-9790-8207
OpenAlex ID: A5083633233
The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study
2021 · Nikita V. Lomakin, Bulat A. Bakirov, et al. · Inflammation Research · 58
PDF
Effectiveness and safety of BCD180, anti-TRBV9+ T-lymphocytes monoclonal antibody in patients with active radiographic axial spondyloarthritis: 36-week results of double-blind randomized placebo-controlled phase II clinical study ELEFTA
2024 · E. L. Nasonov, V. I. Mazurov, et al. · Rheumatology Science and Practice · 18
PDF
Efficacy and safety of levilimab in combination with methotrexate in subjects with rheumatoid arthritis: Results of phase II AURORA study
2021 · V. I. Mazurov, E. G. Zotkin, et al. · Rheumatology Science and Practice · 18
PDF
The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTA
2025 · E. L. Nasonov, V. I. Mazurov, et al. · Doklady Biochemistry and Biophysics · 16
Effectiveness and safety of levilimab in combination with methotrexate in treatment of patients with active rheumatoid arthritis resistant to methotrexate monotherapy (double-blinded randomized placebo controlled phase III clinical study SOLAR)
2021 · V. I. Mazurov, M. A. Korolev, et al. · Modern Rheumatology Journal · 14
PDF
Long-term data on the proposed adalimumab biosimilar BCD-057 in patients with moderate to severe psoriasis: A randomized controlled trial
2022 · Alexey V. Samtsov, Andrey L. Bakulev, et al. · PLoS ONE · 8
PDF
Levilimab in patients with COVID-19 in real-life practice
2021 · E.V. Tavlueva, I.G. Ivanov, et al. · Clinical pharmacology and therapy · 8
PDF
Efficacy and Safety of Levilimab in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: 56-Week Results of Phase III Randomized Double-Blind Placebo-Controlled Trial SOLAR
2024 · V. I. Mazurov, E. L. Nasonov, et al. · Doklady Biochemistry and Biophysics · 5
Efficacy and safety of levilimab in combination with methotrexate in patients with active rheumatoid arthritis: 56-week results of phase III randomized double-blind placebo-controlled trial SOLAR
2023 · V. I. Mazurov, A. M. Lila, et al. · Rheumatology Science and Practice · 5
PDF
The Efficacy and Safety of Divozilimab in Patient with Systemic Sclerosis: 48-Week Results of the Randomized Double-Blind Placebo-Controlled Phase III Clinical Study LIBERIUS
2025 · L. P. Ananyeva, M. N. Starovoytova, et al. · Doklady Biochemistry and Biophysics · 3
PDF
Comparative analysis of the efficacy of seniprutug (BCD-180) and adalimumab in the treatment of active radiographic axial spondyloarthritis: results of a systematic review and matching-adjusted indirect comparison
2024 · A. M. Lila, T. V. Dubinina, et al. · Modern Rheumatology Journal · 3
PDF
Comparative Evaluation of the Long-term Efficacy and Safety of the Infliximab Biosimilar Bcd-055 and Reference Infliximab in Patients With Ankylosing Spondylitis: Results of the International Multicenter Randomized Double-blind Phase Iii Clinical Study Asart-2
2018 · A. M. Lila, V. I. Mazurov, et al. · Rheumatology Science and Practice · 3
The efficacy and safety of Seniprutug in active radiographic axial spondyloathritis and the impact of comorbidity on achieving the clinical effect: the results of 48 weeks of ELEFTA study
2025 · E.L. Nasonov, A.A. Klimenko, et al. · Clinical pharmacology and therapy · 2
PDF
The impact of clinical and demographic factors on the efficacy of divozilimab in patients with systemic sclerosis: Post hoc analysis of the randomized, double-blind, placebo-controlled phase III clinical trial LIBERIUS
2025 · L. P. Ananyeva, A. M. Lila, et al. · Rheumatology Science and Practice · 1
PDF
Levilimab clinical efficacy for interleukin-6 receptor inhibition in COVID-19 and its potential for treating cytokine release syndrome of other aetiologies
2022 · N. V. Lomakin, B. A. Bakirov, et al. · Biological Products Prevention Diagnosis Treatment · 1
PDF
Osteoporosis as a result of the long-term administration of glucocorticoids in patients suffering from acantholytic pemphigus
2016 · M. A. Ufimtseva, YU. M. Bochkarev, et al. · Vestnik dermatologii i venerologii · 1
PDF
P.261 The efficacy and safety of divozilimab, anti-CD20 monoclonal antibody in patients with systemic sclerosis
2026 · Lidia Ananyeva, Liudmila Garzanova, et al. · Poster presentations
Impact of the extraarticular manifestations on the efficacy and tolerability of seniprutug in radiographic axial spondyloarthritis: post hoc analysis of ELEFTA clinical trial
2025 · A. M. Lila, V. I. Mazurov, et al. · Modern Rheumatology Journal
PDF
Extract of oak bark as a selective natural reagent for the spectrophotometric determination of iron (II) in pharmaceutical preparations and blood serum
2025 · V. I. Mazurov, A. M. Lila, et al. · Rheumatology Science and Practice
Slowing the progression of ankylosing spondylitis during long-term therapy with netakimab: results of the international multicenter randomized double-blind phase III clinical trial BCD-085-5/ASTERA
2025 · V. I. Mazurov, A. M. Lila, et al. · Modern Rheumatology Journal
PDF
Pos0649 Efficacy and Safety of Levilimab in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis: 1-year Results of Phase Iii, Double-blind, Placebo-controlled, Randomized Trial
2022 · V. Mazurov, M. Korolev, et al. · Annals of the Rheumatic Diseases
PDF
Prevalence and Predictors of Low Bone Mineral Density in Patients With Multiple Sclerosis in Young Age
2016 · E. L. Turova, E. V. Kozhemyakina, et al. · Almanac of Clinical Medicine
Замедление прогрессирования анкилозирующего спондилита на фоне долгосрочной терапии нетакимабом: результаты международного многоцентрового рандомизированного двойного слепого клинического исследования III фазы BCD-085-5/ASTERA
· Мазуров В. И., Лила А. М., et al. · CyberLeninK (CyberLeninka)
Эффективность и безопасность препарата BCD-180, моноклонального антитела к TRBV9+ T-лимфоцитам, у пациентов с активным рентгенологическим аксиальным спондилоартритом: результаты 36 недель рандомизированного двойного слепого плацебо-контролируемого клинического исследования фазы 2 ELEFTA
· Е. Л. Насонов, В. И. Мазуров, et al. · CyberLeninK (CyberLeninka)
Эффективность и безопасность левилимаба при внутривенном и подкожном введении пациентам с активным ревматоидным артритом: результаты рандомизированного сравнительного двойного слепого контролируемого клинического исследования III фазы LUNAR
· В. И. Мазуров, А. М. Лила, et al. · CyberLeninK (CyberLeninka)
Works count: 26
Citation count: 164
H-index: 7
I10-index: 5
Year
Topic
Type